RICHMOND, Va., November 20, 2025 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), announced today that its Co-Founder and Chief Executive Officer, Dr. Eric S. Edwards, M.D., Ph.D., testified before the United...
2025
Safeguarding Essential Medicines in an Uncertain World
Phlow is honored to be featured in Inc. Magazine and Fast Company as part of The Resiliency Playbook, an inspiring series powered by SAP that spotlights businesses born to solve a crisis and built for generational impact. The feature — paired with a video interview...
Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corporation on a Historic Investment to Create the Nation’s Largest Workforce Development Center for Advanced Pharmaceutical Manufacturing
RICHMOND, Va., November 3, 2025 – Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), congratulates Governor Glenn Youngkin, the Virginia Innovation Partnership Corporation (VIPC), and several leading...
Phlow Corp. Selected by the U.S. Food and Drug Administration Commissioner’s First-Ever National Priority Voucher Pilot Program to Advance Manufacturing of a Critical Essential Medicine in America
RICHMOND, Va., October 16, 2025 – Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that the active pharmaceutical ingredient for ketamine will be included in the first-ever U.S. Food...
Phlow Appoints Tim M. Mayleben as Chairman of the Board, Building on Bold Leadership and Expanding America’s Medicine Manufacturing Future
RICHMOND, Va, Oct. 15, 2025 — Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced that current board member and former advisory board member Tim M. Mayleben has been appointed Chairman of the Board...
Phlow Observes 5th Annual National Essential Medicine Shortage Awareness Day, Accelerating Efforts to Strengthen America’s Medicine Supply Chain
RICHMOND, Va., September 8, 2025 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today reaffirmed its commitment to addressing the nation’s drug shortage crisis as it observes the 5th annual National...
Built for Resilience: The Strategic Active Pharmaceutical Ingredient Reserve (SAPIR).
Phlow Corp. Applauds Executive Action to Operationalize the Strategic Active Pharmaceutical Ingredient Reserve (SAPIR).
Richmond, VA – August 14, 2025 – Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American pharmaceutical supply chain resiliency by filling and operationalizing the Strategic Active Pharmaceutical Ingredient Reserve...
Phlow Corp. and Antheia Partner to Bolster U.S. Pharmaceutical Supply Chains with Advanced Manufacturing Technologies
RICHMOND, Va., and MENLO PARK, Calif., July 29, 2025 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO) and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains,...
Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America
Richmond, VA., July 22, 2025 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased valuation from previous funding....